KINGDON CAPITAL MANAGEMENT, L.L.C. - Q4 2020 holdings

$925 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 56 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .

 Value Shares↓ Weighting
XBI NewSPDR SER TRput$42,234,000300,000
+100.0%
4.57%
BIDU NewBAIDU INCspon adr rep a$22,881,000105,815
+100.0%
2.48%
FLEX NewFLEX LTDord$14,166,000787,900
+100.0%
1.53%
IOVA NewIOVANCE BIOTHERAPEUTICS INCput$13,920,000300,000
+100.0%
1.51%
BHVN NewBIOHAVEN PHARMACTL HLDG CO Lcall$12,857,000150,000
+100.0%
1.39%
RADI NewRADIUS GLOBAL INFRASTRCTRE I$12,850,0001,000,000
+100.0%
1.39%
SUMO NewSUMO LOGIC INCput$11,432,000400,000
+100.0%
1.24%
WDAY NewWORKDAY INCcl a$11,381,00047,500
+100.0%
1.23%
BFT NewFOLEY TRASIMENE ACQUISITION$8,689,000575,450
+100.0%
0.94%
TWLO NewTWILIO INCput$7,481,00022,100
+100.0%
0.81%
WDAY NewWORKDAY INCput$5,990,00025,000
+100.0%
0.65%
STPK NewSTAR PEAK ENERGY TRANSITIONcl a$5,852,000286,000
+100.0%
0.63%
DIS NewDISNEY WALT COput$5,544,00030,600
+100.0%
0.60%
GOOS NewCANADA GOOSE HLDGS INC$5,409,000181,700
+100.0%
0.58%
FOUR NewSHIFT4 PMTS INCcl a$5,278,00070,000
+100.0%
0.57%
RAPT NewRAPT THERAPEUTICS INC$5,009,000253,608
+100.0%
0.54%
TENB NewTENABLE HLDGS INCput$3,825,00073,200
+100.0%
0.41%
GEG NewGREAT ELM GROUP INC$3,626,0001,259,049
+100.0%
0.39%
WORK NewSLACK TECHNOLOGIES INC$3,168,00075,000
+100.0%
0.34%
PD NewPAGERDUTY INCcall$2,181,00052,300
+100.0%
0.24%
EUCRU NewEUCRATES BIOMEDICAL ACQU CORunit 10/23/2027$2,132,000200,000
+100.0%
0.23%
CRC NewCALIFORNIA RES CORP$689,00029,199
+100.0%
0.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (924515000.0 != 924512000.0)

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings